Lakefront Biotherapeutics (LKFT) Operating Income Growth (1y) (2015 - 2026)
Lakefront Biotherapeutics (LKFT) Operating Income Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | - |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - | - |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | 1,386.07% |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.54 Bn | 1.91 Mn | 59.86% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 59.86% |
| Dec 31, 2025 | 961.99% |
| Sep 30, 2025 | -137.54% |
| Jun 30, 2025 | 54.96% |
| Mar 31, 2025 | -379.03% |
| Dec 31, 2024 | -67.19% |
| Sep 30, 2024 | -1,264.04% |
| Jun 30, 2024 | 851.19% |
| Mar 31, 2024 | -133.35% |
| Dec 31, 2023 | 5,332.50% |
| Sep 30, 2023 | 62.15% |
| Jun 30, 2023 | 82.32% |
| Mar 31, 2023 | 32.86% |
| Dec 31, 2022 | -3.19% |
| Sep 30, 2022 | 78.62% |
| Jun 30, 2022 | -63.32% |
| Mar 31, 2022 | 58.37% |
| Dec 31, 2021 | 102.31% |
| Sep 30, 2021 | -4.77% |
| Jun 30, 2021 | 46.98% |